Skip to main content
. 2007 Jan 31;8(8):571–583. doi: 10.1111/j.1524-6175.2006.05636.x

Figure 2.

Figure 2

Percentage of patients within the four different treatment groups that reached target levels for both blood pressure and low‐density lipoprotein cholesterol at Week 8 (left panel) and Week 28 (right panel, stratified by the original randomized double‐blind treatment groups); data for risk groups I, II, and III combined. At Week 28, all patients were receiving coadministered amlodipine (AML) and atorvastatin (ATV). *p<0.001 vs. amlodipine alone; **p<0.001 vs. atorvastatin alone